Cargando…
The need for inclusion of pregnant women in COVID-19 vaccine trials
Autores principales: | Beigi, Richard H., Krubiner, Carleigh, Jamieson, Denise J., Lyerly, Anne D., Hughes, Brenna, Riley, Laura, Faden, Ruth, Karron, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798437/ https://www.ncbi.nlm.nih.gov/pubmed/33446385 http://dx.doi.org/10.1016/j.vaccine.2020.12.074 |
Ejemplares similares
-
Prioritization of pregnant individuals in state plans for coronavirus disease 2019 vaccination
por: Crane, Matthew A., et al.
Publicado: (2021) -
Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response()
por: Krubiner, Carleigh B., et al.
Publicado: (2021) -
Global disparities in public health guidance for the use of COVID-19 vaccines in pregnancy
por: Zavala, Eleonor, et al.
Publicado: (2022) -
Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications
por: Wonodi, Chizoba, et al.
Publicado: (2022) -
Ending the evidence gap for pregnancy, HIV and co‐infections: ethics guidance from the PHASES project
por: Lyerly, Anne Drapkin, et al.
Publicado: (2021)